Improving cervical cancer screening rates: a scoping review of resources and interventions

Popalis, Madyson L.; Ramirez, Sarah I.; Leach, Kelsey M.; Granzow, Marni E.; Stoltzfus, Kelsey C.; Moss, Jennifer L.

doi:10.1007/s10552-022-01618-2

Cited by 9 publications

(1 citation statement)

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Therefore, effective screening methods for cervical cancer have become an important tool for detecting, interrupting and reducing the occurrence of cervical cancer. However, the study shows that only 81% of women aged 21–65 are up-to-date on screening [ 3 ]. Currently, cervical cancer screening is mainly performed by cervical cytology, colposcopy, cervical biopsy, and high-risk Human Papillomavirus (HPV) [ 4 ], that often causes delays in many patients due to problems in obtaining the material.…”

Section: Introductionmentioning

confidence: 99%

Research progress of metabolomics in cervical cancer

Jia,

Zou,

Zou

2023

Eur J Med Res

View full text Add to dashboard Cite

Introduction Cervical cancer threatens women's health seriously. In recent years, the incidence of cervical cancer is on the rise, and the age of onset tends to be younger. Prevention, early diagnosis and specific treatment have become the main means to change the prognosis of cervical cancer patients. Metabolomics research can directly reflect the changes of biochemical processes and microenvironment in the body, which can provide a comprehensive understanding of the changes of metabolites in the process of disease occurrence and development, and provide new ways for the prevention and diagnosis of diseases. Objectives The aim of this study is to review the metabolic changes in cervical cancer and the application of metabolomics in the diagnosis and treatment. Methods PubMed, Web of Science, Embase and Scopus electronic databases were systematically searched for relevant studies published up to 2022. Results With the emergence of metabolomics, metabolic regulation and cancer research are further becoming a focus of attention. By directly reflecting the changes in the microenvironment of the body, metabolomics research can provide a comprehensive understanding of the patterns of metabolites in the occurrence and development of diseases, thus providing new ideas for disease prevention and diagnosis. Conclusion With the continuous, in-depth research on metabolomics research technology, it will bring more benefits in the screening, diagnosis and treatment of cervical cancer with its advantages of holistic and dynamic nature.

show abstract

Section: Introductionmentioning

confidence: 99%

Research progress of metabolomics in cervical cancer

Jia,

Zou,

Zou

2023

Eur J Med Res

View full text Add to dashboard Cite

show abstract

Screening Methods for Cervical Cancer

Li,

Adobo,

Shi

et al. 2024

ChemMedChem

View full text Add to dashboard Cite

Cervical cancer seriously affects the health of women worldwide. Persistent infection of high‐risk HPV (Human Papilloma Virus) can lead to cervical cancer. There is a great need for timely and efficient screening methods for cervical cancer. The current screening methods for cervical cancer are mainly based on cervical cytology and HPV testing. Cervical cytology is made of Pap smear and liquid‐based cytology, while HPV testing is based on immunological and nucleic acid level detection methods. This review introduces cervical cancer screening methods based on cytology and human papillomavirus testing in detail. The advantages and limitations of the screening methods are also summarized and compared.

show abstract